Insights

Loading spinner
Gathering insights about Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc. Tech Stack

Arsenal Biosciences, Inc. uses 8 technology products and services including Ansible, Docker, NetSuite, and more. Explore Arsenal Biosciences, Inc.'s tech stack below.

  • Ansible
    Configuration Management
  • Docker
    Containerization
  • NetSuite
    E-commerce
  • Microsoft
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Java
    Programming Languages
  • VMware
    Virtualisation Software
  • Smush
    Web Tools And Plugins

Media & News

Arsenal Biosciences, Inc.'s Email Address Formats

Arsenal Biosciences, Inc. uses at least 1 format(s):
Arsenal Biosciences, Inc. Email FormatsExamplePercentage
FLast@arsenalbio.comJDoe@arsenalbio.com
88%
Last@arsenalbio.comDoe@arsenalbio.com
7%
First@arsenalbio.comJohn@arsenalbio.com
4%
FL@arsenalbio.comJD@arsenalbio.com
1%

Frequently Asked Questions

What is Arsenal Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s official website is arsenalbio.com and has social profiles on LinkedIn.

What is Arsenal Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arsenal Biosciences, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Arsenal Biosciences, Inc. has approximately 281 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Scientific Officer: N. H.Chief Financial Officer: J. S.Vice President Of Quality: P. H.. Explore Arsenal Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Arsenal Biosciences, Inc. belong to?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Arsenal Biosciences, Inc. use?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s tech stack includes AnsibleDockerNetSuiteMicrosoftMicrosoft AzureJavaVMwareSmush.

What is Arsenal Biosciences, Inc.'s email format?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s email format typically follows the pattern of FLast@arsenalbio.com. Find more Arsenal Biosciences, Inc. email formats with LeadIQ.

How much funding has Arsenal Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Arsenal Biosciences, Inc. has raised $85M in funding. The last funding round occurred on Oct 17, 2019 for $85M.

When was Arsenal Biosciences, Inc. founded?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc. was founded in 2019.

Arsenal Biosciences, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $85M

    Arsenal Biosciences, Inc. has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $100M$250M

    Arsenal Biosciences, Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $85M

    Arsenal Biosciences, Inc. has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $100M$250M

    Arsenal Biosciences, Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.